USP1 inhibition induces single strand DNA gap accumulation and overcomes PARP inhibitor resistance in BRCA1 deficient cancer cells

被引:0
|
作者
da Costa, Alexandre A. B. A.
Somuncu, Ozge
Ravindranathan, Ramya
Mukkavalli, Sirisha
Martignetti, David B.
Nguyen, Huy
Jiao, Yuqing
Lamarre, Benjamin
Moreau, Lisa
Liu, Joyce
Iyer, Divya
Lazaro, Jean-Bernard
Shapiro, Geoffrey I.
Parmar, Kalindi
D'Andrea, Alan D.
机构
关键词
D O I
10.1158/1538-7445.DNAREPAIR24-B032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B032
引用
收藏
页数:2
相关论文
共 50 条
  • [21] STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
    Qiwei Wang
    Johann S. Bergholz
    Liya Ding
    Ziying Lin
    Sheheryar K. Kabraji
    Melissa E. Hughes
    Xiadi He
    Shaozhen Xie
    Tao Jiang
    Weihua Wang
    Jason J. Zoeller
    Hye-Jung Kim
    Thomas M. Roberts
    Panagiotis A. Konstantinopoulos
    Ursula A. Matulonis
    Deborah A. Dillon
    Eric P. Winer
    Nancy U. Lin
    Jean J. Zhao
    Nature Communications, 13
  • [22] STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
    Wang, Qiwei
    Bergholz, Johann S.
    Ding, Liya
    Lin, Ziying
    Kabraji, Sheheryar K.
    Hughes, Melissa E.
    He, Xiadi
    Xie, Shaozhen
    Jiang, Tao
    Wang, Weihua
    Zoeller, Jason J.
    Kim, Hye-Jung
    Roberts, Thomas M.
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Dillon, Deborah A.
    Winer, Eric P.
    Lin, Nancy U.
    Zhao, Jean J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [23] Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMS
    Pachkowski, Brian F.
    Tano, Keizo
    Afonin, Valeriy
    Elder, Rhoderick H.
    Takeda, Shunichi
    Watanabe, Masami
    Swenberg, James A.
    Nakamura, Jun
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 671 (1-2) : 93 - 99
  • [24] Targeting the PI3K Pathway Enhances the Effect of PARP-1 Inhibition in BRCA1 Deficient Breast Cancer Cells
    Kimbung, S.
    Aaltonen, K.
    Gruvberger-Saal, S.
    Berglund, P.
    Hedenfalk, I.
    CANCER RESEARCH, 2010, 70
  • [25] PLK1 inhibition overcomes PARP inhibitor resistance in triple-negative breast cancer
    Siraj, Abdul K.
    Poyil, Pratheesh Kumar
    Padmaja, Divya
    Parvathareddy, Sandeep Kumar
    Alobaisi, Khadija
    Begum, Rafia
    Almalik, Osama
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Loss of Rev7 causes PARP inhibitor resistance in BRCA1;p53-deficient mouse mammary tumor cells
    Xu, Guotai
    Bouwman, Peter
    Jaspers, Janneke
    Pieterse, Mark
    Kersbergen, Ariena
    Jonkers, Jos
    Borst, Piet
    Rottenberg, Sven
    CANCER RESEARCH, 2012, 72
  • [27] USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells
    Lu, Qin
    Zhang, Fang-Lin
    Lu, Da-Yun
    Shao, Zhi-Ming
    Li, Da-Qiang
    CANCER MEDICINE, 2019, 8 (15): : 6730 - 6740
  • [28] Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
    Henneman, Linda
    van Miltenburg, Martine H.
    Michalak, Ewa M.
    Braumuller, Tanya M.
    Jaspers, Janneke E.
    Drenth, Anne Paulien
    de Korte-Grimmerink, Renske
    Gogola, Ewa
    Szuhai, Karoly
    Schlicker, Andreas
    Bin Ali, Rahmen
    Pritchard, Colin
    Huijbers, Ivo J.
    Berns, Anton
    Rottenberg, Sven
    Jonkers, Jos
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (27) : 8409 - 8414
  • [29] DYNLL1 INHIBITS DNA END RESECTION IN BRCA1-DEFICIENT CELLS AND REGULATES PARP INHIBITOR SENSITIVITY
    He, Yizhou Joseph
    Meghani, Khyati
    Caron, Marie-Christine
    Yang, Chunyu
    Ronato, Daryl A.
    Bian, Jie
    Sharma, Anchal
    Miller, Jessica
    Joshi, Niraj
    Detappe, Alexandre
    Doench, John G.
    Legube, Gaelle
    Root, David E.
    D'Andrea, Alan D.
    Drane, Pascal
    De, Subhojyoti
    Konstantinopoulos, Panagiotis
    Masson, Jean-Yves
    Chowdhury, Dipanjan
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 90 - 90
  • [30] LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
    Ling, Min
    Liu, Qing
    Wang, Yufei
    Liu, Xueting
    Jiang, Manli
    Hu, Jinyue
    FRONTIERS IN ONCOLOGY, 2022, 12